Practical methods for improving flow properties of active pharmaceutical ingredients

Drug Development and Industrial Pharmacy

Volumn 35, Issue 12, 2009, Pages 1460-1469

  Pingali, Kalyana C ^a   Saranteas, Kostas ^b   Foroughi, Reza ^b   Muzzio, Fernando J ^a  

^a The State University of New Jersey   (United States)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Cohesion; Dilation; Drug; Flow index; Impedance; Powder flow

Indexed keywords

DINORSIBUTRAMINE TARTRATE; DRUG ADDITIVE; GLIDING AGENT; LEVALBUTEROL; LUBRICATING AGENT; MAGNESIUM STEARATE; PARACETAMOL; SIBUTRAMINE; SILICON DIOXIDE; TALC; UNCLASSIFIED DRUG;

ARTICLE; DRUG FORMULATION; FLOW KINETICS; FLOW MEASUREMENT; HUMAN; MATERIALS TESTING; POWDER;

ACETAMINOPHEN; ALBUTEROL; CHEMISTRY, PHARMACEUTICAL; COLLOIDS; CYCLOBUTANES; DRUG COMPOUNDING; ELECTRIC IMPEDANCE; EXCIPIENTS; PARTICLE SIZE; PHYSICOCHEMICAL PHENOMENA; POWDERS; RHEOLOGY; SILICON DIOXIDE; STEARIC ACIDS; TALC; TECHNOLOGY, PHARMACEUTICAL;

EID: 71049181446     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639040903025830     Document Type: Article

References (40)

1. Hancock BC, Carlson GT, Ladipo DD, Langdon BA, Mullarney MP. (2002). Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance. Int J Pharm, 241:73-85.
2. Kumar TM, Misra A. (2006). Formulation and evaluation of insulin dry powder for inhalation. Drug Dev Ind Pharm, 32:677-686
3. Visser J. (1989). An invited review: Van der Waals and other cohesive forces affecting powder fluidization. Powder Technol, 58:1-10.
4. Hickey AJ, Concessio NM, VanOort MM, Platz RM. (1994). Factors influencing the dispersion of dry powders as aerosols. Pharm Tech, 18:58-64.
5. Podczeck F. (1998). Adhesion forces in interactive powder mixtures of a micronized drug and carrier particles of various particle size distributions. J Adhes Sci Technol, 12:1323-1339
6. Rasenack N, Steckel H, Muller BW. (2003). Micronization of anti-inflammatory drugs for pulmonary delivery by a controlled crystallization process. J Pharm Sci, 92:35-44.
7. York P. (1994). Powdered raw materials: Characterizing batch uniformity. Respir Drug Deliv, 4:83-91.
8. Senjkovic R, Becirevic M, Usmiani I. (1992). Effect of fillers on the properties of paracetamol and acetylsalicylic-acid tablets prepared by direct compression. Pharm Ind, 54:555-557
9. Calatayud JM, Garcia JV. (1993). Online solid-phase reactors for unsegmented continuous-flow drug analysis. Trends Anal Chem, 12:428-436
10. Antikainen OK, Rantanen JT, Yliruusi JK. (2000). Use of the Kohonen self-organising map to predict the flowability of powders. STP Pharm Sci, 10:349-354
11. Millan M, Caraballo I, Rabasco AM. (1998). The role of the drug/excipient particle size ratio in the percolation model for tablets. Pharm Res, 15:216-220
12. Podczeck F. (1998). The relationship between physical properties of lactose monohydrate and the aerodynamic behaviour of adhered drug particles. Int J Pharm, 160:119-130
13. Devilliers MM. (1995). Influence of cohesive properties of micronized drug powders on particle-size analysis. J Pharm Biomed Anal, 13:191-198
14. Concessio NM, VanOort MM, Knowles MR, Hickey AJ. (1999). Pharmaceutical dry powder aerosols: Correlation of powder properties with dose delivery and implications for pharmacodynamic effect. Pharm Res, 16:828-834
15. Ong JTH, Chowhan ZT, Samuels GJ. (1993). Drug-excipient interactions resulting from powder mixing. 6. Role of various surfactants. Int J Pharm, 96:231-242
16. Podczeck F, Newton M, James MB. (1995). The assessment of particle friction of a drug substance and a drug carrier substance. J Mater Sci, 30:6083-6089
17. Sheskey PJ, Robb RT, Moore RD, Boyce BM. (1995). Effects of lubricant level, method of mixing, and duration of mixing on a controlled-release matrix tablet containing hydroxypropyl methylcellulose. Drug Dev Ind Pharm, 21:2151-2165
18. Wang LH, Chowhan ZT. (1990). Drug-excipient interactions resulting from powder mixing. 5. Role of sodium lauryl sulfate. Int J Pharm, 60:61-78.
19. Rizk S, Guyot JC, Duru C, Gaudy D. (1995). Influence of lubricant properties on compression behaviour and drug dissolution rate of scleroglucan hydrophilic matrix. Int J Pharm, 126:57-63.
20. Morris LE, Moore JC, Schwartz JB. (1996). Characterization and performance of a new direct compression excipient for chewable tablets: Xylitab(R). Drug Dev Ind Pharm, 22:925-932
21. Turkoglu M, Ozarslan R, Sakr A. (1995). Artificial neural-network analysis of a direct compression tabletting study. Eur J Pharm Biopharm, 41:315-322
22. York P. (1992). Crystal engineering and particle design for the powder compaction process. Drug Dev Ind Pharm, 18:677-721.
23. Wong ACY. (2000). Characterisation of the flowability of glass beads by bulk densities ratio. Chem Eng Sci, 55:3855-3859
24. Faqih A, Chaudhuri B, Alexander AWA, Muzzio FJ, Tomassone MS. (2006). Flow induced dilation of cohesive granular materials. AIChE, 52:4124-4132
25. Leuenberger G, Ludwig R, Apelian D. (2002). Modeling of conductivity versus density behavior in green-state powder metallurgy compacts. J Nondestruct Eval, 21:111-116
26. Aly SAS. (2006). The resistance to compression index as a parameter to evaluate the efficacy of lubricants in pharmaceutical tabletting. J Drug Delivery Sci Technol, 16:151-155
27. Pingali KC, Muzzio FJ, Shinbrot T. (2009). An observed correlation between flow and electrical properties of pharmaceutical blends. Powder Technol, 192:157-165
28. Egermann H, Frank P. (1990). Novel approach to estimate quality of binary random powder mixtures: Samples of constant volume. II-Applications of equation to optimize tableting conditions. J Pharm Sci, 81:667-669
29. Kornchankul W, Hamed E, Parikh N, Sakr A. (2002). Effect of the drug proportion and mixing time on the content uniformity of a low dose drug in a high shear mixer. Pharmazie, 57:49-53.
30. Otsuka M, Gao J, Matsuda Y. (1993). Effects of mixer and mixing time on the pharmaceutical properties of theophilline tablets containing various kinds of lactose as diluents. Drug Dev Ind Pharm, 19:333-348
31. Carr RL. (1965). Evaluating flow properties of solids. Chem Eng, 72:163-168
32. Lindberg NO, Palsson M, Pihl AC, Freeman R., Freeman T, Zetzener H, Enstad G. (2004). Flowability measurements of pharmaceutical powder mixtures with poor flow using five different techniques. Drug Dev Ind Pharm, 30:785-791
33. Eilbeck J, Rowley G, Carter PA, Fletcher EJ. (2000). Effect of contamination of pharmaceutical equipment on powder triboelectrification. Int J Pharm, 195:7-11.
34. Nishiyama T, Yunoki K, Honda T, Yazawa H. (1998). Evaluation of the electrostatic properties of pharmaceutical powders during pneumatic conveying. Nippon Kagaku Kaishi, 201-206
35. Rowley G. (2001). Quantifying electrostatic interactions in pharmaceutical solid systems. Int J Pharm, 227:47-55.
36. Michrafy A, Ringenbacher D, Tchoreloff P. (2002). Modelling the compaction behaviour of powders: Application to pharmaceutical powders. Powder Technol, 127:257-266
37. Oyebola MT, Podczeck F, Barrett D. (2004). The influence of particle size and relative humidity of air on the shear properties of pharmaceutical powders. Eur J Pharm Sci, 23:S46.
38. Engers DA, Fricke MN, Storey RP, Newman AW, Morris KR. (2006). Triboelectrification of pharmaceutically relevant powders during low-shear tumble blending. J Electrstat, 12:826-835
39. Watanabe H, Samimi A, Ding YL, Ghadiri M, Matsuyama T, Pitt KG. (2006). Measurement of charge transfer due to single particle impact. Part Part Syst Char, 23:133-137
40. Alexander AA, Choudhuri B, Faqih AM, Muzzio FJ, Davies C, Tomassone MS. (2006). Avalanching flow of cohesive powders. Powder Technol, 164:13-21.